Pfizer maneuvers to protect Lipitor from generics
Tuesday, November 29, 2011 - 16:30
in Mathematics & Economics
(AP) -- Lipitor is so valuable that its maker, Pfizer Inc., is practically paying people to keep taking the blockbuster cholesterol medicine after generic competition hits the U.S. market this week.